Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma—The RAPPORT Trial-Reference-Cited by-同舟云学术

Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma—The RAPPORT Trial

Published:2021-12 Issue: Volume: Page:
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Siva Shankar,Bressel Mathias,Wood Simon T.,Shaw Mark G.,Loi Sherene,Sandhu Shahneen K.,Tran Ben,A. Azad Arun,Lewin Jeremy H.,Cuff Katharine E.,Liu Howard Y.,Moon Daniel,Goad Jeremy,Wong Lih-Ming,LimJoon Michael,Mooi Jennifer,Chander Sarat,Murphy Declan G.,Lawrentschuk Nathan,Pryor David

Publisher

Elsevier BV

Subject

Urology

Reference31 articles.

1. Treatment options for de novo metastatic clear-cell renal cell carcinoma: current recommendations and future insights;Benamran;Eur Urol Oncol,2021

2. Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach;Siva;Nat Rev Urol,2017

3. A review of human cell radiosensitivity in vitro;Deschavanne;Int J Radiat Oncol Biol Phys,1996

4. Temporal trends and predictors in the use of stereotactic body radiotherapy for treatment of metastatic renal cell carcinoma in the US;Paciotti;Oncologist,2021

5. Safety and survival rates associated with ablative stereotactic radiotherapy for patients with oligometastatic cancer: a systematic review and meta-analysis;Lehrer;JAMA Oncol,2021

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Radiotherapy as a Promising Alternative for Managing Advanced Upper Tract Urothelial Carcinoma: Rescuing Chemotherapy-Intolerant Patients;Clinical Genitourinary Cancer;2024-12

2. Changes in the overall survival of patients with metastatic renal cell carcinoma in the era of immune-checkpoint inhibitors;Cancer Epidemiology;2024-10

3. Focal therapy for oligometastatic and oligoprogressive renal cell carcinoma: a narrative review;Future Oncology;2024-09-11

4. Renal cell carcinoma;The Lancet;2024-08

5. The Landscape of Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Cancer (RCC);Cancers;2024-07-27